NasdaqGS - Delayed Quote USD

Treace Medical Concepts, Inc. (TMCI)

10.40 +0.10 (+0.97%)
At close: April 26 at 4:00 PM EDT
10.45 +0.05 (+0.48%)
After hours: April 26 at 6:05 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
187,118.00
187,118.00
141,838.00
94,419.00
57,365.00
Cost of Revenue
35,181.00
35,181.00
25,532.00
16,888.00
12,470.00
Gross Profit
151,937.00
151,937.00
116,306.00
77,531.00
44,895.00
Operating Expense
203,365.00
203,365.00
151,150.00
94,041.00
44,040.00
Operating Income
-51,428.00
-51,428.00
-34,844.00
-16,510.00
855.00
Net Non Operating Interest Income Expense
1,559.00
1,559.00
-3,085.00
-4,043.00
-4,523.00
Other Income Expense
342.00
342.00
-4,886.00
1.00
--
Pretax Income
-49,527.00
-49,527.00
-42,815.00
-20,552.00
-3,668.00
Net Income Common Stockholders
-49,527.00
-49,527.00
-42,815.00
-20,748.00
-4,308.00
Diluted NI Available to Com Stockholders
-49,527.00
-49,527.00
-42,815.00
-20,748.00
-4,308.00
Basic EPS
-0.78
-0.81
-0.77
-0.43
-0.10
Diluted EPS
-0.78
-0.81
-0.77
-0.43
-0.10
Basic Average Shares
59,308.89
60,852.15
55,276.83
48,415.68
43,903.27
Diluted Average Shares
59,308.89
60,852.15
55,276.83
48,415.68
43,903.27
Total Operating Income as Reported
-51,428.00
-51,428.00
-34,844.00
-16,510.00
855.00
Total Expenses
238,546.00
238,546.00
176,682.00
110,929.00
56,510.00
Net Income from Continuing & Discontinued Operation
-49,527.00
-49,527.00
-42,815.00
-20,552.00
-3,668.00
Normalized Income
-49,527.00
-49,527.00
-38,332.00
-20,552.00
-3,668.00
Interest Income
6,726.00
6,726.00
1,313.00
17.00
--
Interest Expense
5,167.00
5,167.00
4,398.00
4,060.00
4,523.00
Net Interest Income
1,559.00
1,559.00
-3,085.00
-4,043.00
-4,523.00
EBIT
-44,360.00
-44,360.00
-38,417.00
-16,492.00
855.00
EBITDA
-39,008.00
-39,008.00
-36,284.00
-15,807.00
2,065.00
Reconciled Cost of Revenue
35,181.00
35,181.00
25,532.00
16,888.00
12,470.00
Reconciled Depreciation
5,352.00
5,352.00
2,133.00
685.00
1,210.00
Net Income from Continuing Operation Net Minority Interest
-49,527.00
-49,527.00
-42,815.00
-20,552.00
-3,668.00
Total Unusual Items Excluding Goodwill
--
--
-4,483.00
--
--
Total Unusual Items
--
--
-4,483.00
--
--
Normalized EBITDA
-39,008.00
-39,008.00
-31,801.00
-15,807.00
2,065.00
12/31/2020 - 4/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FNA Paragon 28, Inc.
8.80
-1.90%
 
SGHT Sight Sciences, Inc.
5.28
+2.72%
 
CTKB Cytek Biosciences, Inc.
5.76
+2.31%
 
PRCT PROCEPT BioRobotics Corporation
51.83
-0.86%
 
SIBN SI-BONE, Inc.
14.57
+2.10%
 
KIDS OrthoPediatrics Corp.
30.26
+1.07%
 
CVRX CVRx, Inc.
14.69
+2.08%
 
OFIX Orthofix Medical Inc.
12.99
-0.84%
 
NVRO Nevro Corp.
11.32
-2.58%
 
XTNT Xtant Medical Holdings, Inc.
0.9500
+5.38%